• Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
HBOT News Network Logo
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications
Veterans Special Report
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications

Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients – a retrospective analysis.

by HBOT News | Feb 27, 2020 | Stroke

Abstract:   BackgroundPrevious studies have shown that hyperbaric oxygen therapy (HBOT) can improve the motor functions and memory of post-stroke patients in the chronic stage. ObjectiveThe aim of this study is to evaluate the effects of HBOT on overall cognitive...

Fitness genes of group A streptococci in necrotizing fasciitis and myositis.

by HBOT News | Feb 1, 2020 | Necrotizing Fasciitis

Abstract: Necrotizing fasciitis and myositis caused by group A streptococci (GAS) are among the most fulminating infections, with a mortality rate of 20% to 30%. Although numerous regimens have been utilized in attempts to control these devastating infections, such as...

Asymptomatic Patients Received Repetitive HBOT Protocols to Evaluate Sustained Cardiac Effect

by HBOT News | Jan 30, 2020 | Cardiac Heart News

One of the largest hyperbaric treatment centers in the world, The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, announced exciting results from a recent study; leading the medical industry to believe that a HBOT protocol could indeed be...

The effect of hyperbaric oxygenation therapy on myocardial function

by HBOT News | Jan 13, 2020 | Heart Disease

Abstract: Hyperbaric oxygenation therapy is successfully implemented for the treatment of several disorders. Data on the effect of hyperbaric oxygenation on echocardiographic parameters in asymptomatic patients is limited. The current study sought to evaluate the...

Clinical Trial – Subarachnoid Bupivacaine in Obese Patients Undergoing Cesarean Delivery

by HBOT News | Dec 7, 2019 | Anesthesia, Clinical Trials, HBOT Research, Obstetrical

This study evaluates the effect of subarachnoid hyperbaric bupivacaine on mean arterial blood
pressure (MAP) of pregnant patients with obesity undergoing cesarean section half of the
patients will receive subarachnoid hyperbaric bupivacaine at a dose of 5 mg while the other
half will receive a dose of 10 mg

« Older Entries
Next Entries »

Recent Posts

  • Treat the Concussion: How HBOT Is Changing the Playbook for Concussions — An Interview with Dr. Daphne Denham
  • Understanding Hyperbaric Chambers: Types, Risks, and Safety Tips for Patients
  • Overcoming the Placebo Challenge: New Trial Confirms HBOT Benefits for TBI and PTSD
  • Concussion Recovery: New Study Supports HBOT for Student Athletes
  • Can Oxygen Make You Younger? What Bryan Johnson’s $2M HBOT Experiment Really Tells Us

Archives

Categories

Hyperbaric Oxygen Therapy is used around the world to extend and improve quality of life by augmenting the treatment of all injuries, diseases and infections, as well as to improve overall wellness. HBOT involves breathing 100% oxygen in a pressurized chamber to increase oxygen levels in blood plasma. A century of clinical research has shown that increased oxygen in plasma accelerates our natural ability to heal through neurogenesis and angiogenesis.
  • Follow
  • Follow
  • Follow
  • Follow
  • Policies
  • Contact

Our Newsletter

Join our mailing list and get notified when we publish news or record new episodes.

Name(Required)

© 2015-2023 HBOT News – Your news source for the latest news and research about hyperbaric oxygen therapy.